Publications:

Targeting the Ezrin Adaptor Protein Sensitizes Metastatic Breast Cancer Cells to Chemotherapy and Reduces Neoadjuvant Therapy-induced Metastasis.

Cancer Research Communications

Hoskin, Victoria V; Ghaffari, Abdi A; Laight, Brian J BJ; SenGupta, Sandip S; Madarnas, Yolanda Y; Nicol, Christopher J B CJB; Elliott, Bruce E BE; Varma, Sonal S; Greer, Peter A PA

Publication Date: 2022-06

Variant appearance in text: PTEN: L194F

PubMed Link: 36923551

Variant Present in the following documents:

• crc-21-0117-s01.pdf

View BVdb publication page

Identification of potential new treatment response markers and therapeutic targets using a Gaussian process-based method in lapatinib insensitive breast cancer models.

Plos One

Santra, Tapesh T; Roche, Sandra S; Conlon, Neil N; O'Donovan, Norma N; Crown, John J; O'Connor, Robert R; Kolch, Walter W

Publication Date: 2017

Variant appearance in text: PTEN: L194F

PubMed Link: 28481952

Variant Present in the following documents:

• Main text
• pone.0177058.pdf

View BVdb publication page

Genome-wide effects of MELK-inhibitor in triple-negative breast cancer cells indicate context-dependent response with p53 as a key determinant.

Plos One

Simon, Marisa M; Mesmar, Fahmi F; Helguero, Luisa L; Williams, Cecilia C

Publication Date: 2017

Variant appearance in text: PTEN: L194F

PubMed Link: 28235006

Variant Present in the following documents:

• Main text
• pone.0172832.pdf

View BVdb publication page